Send the following on WhatsApp
Continue to Chathttps://oncoletter.ch/share/?p=twitter&u=http%3A%2F%2Fweb.oncoletter.ch%2Fkongressberichte-live-webcasts%2Fthe-21st-eha-annual-congress%2Feha-highlights-presented-at-the-press-conference%2Ffriday-june-3.html&t=Daratumumab%3A%20the%20POLLUX%20study%3B%20comment%20Prof.%20Markus%20Manz%3A%20blinatumomab%20in%20ALL%20%28TOWER%29%3B%20pre-leukemic%20clones%20linked%20to%20recurrence%3B%20the%20EURO-SKI%20trial%3B%20major%20bleeding%20in%20NOACs%20or%20VKAs%3B%20%20nivolumab%20in%20hodgkin%20lymphoma%20%20ibrutinib%20in%20del17p%20CLL%3B%20Thrombocytopenia